September is Childhood Cancer Awareness Month, and Kneaders Bakery and Cafe is encouraging customers to join them in their unique campaign to fight childhood cancer, one delicious cookie at a time!... Read More
Working to Understand Who Develops Cancer and Why
The Schiffman Lab studies pediatric hereditary cancer syndromes, with a special interest in genetic susceptibility to childhood cancers. Our research investigates molecular changes in childhood cancers, as well as the germline genetic variation that gives rise to childhood tumors. It is our goal to find out who gets cancer and why, so that we can develop ways to better predict, prevent, and treat cancer in the clinic.
All of our studies include the perspective of evolutionary (Darwinian) medicine, with a focus on comparative oncology to identify universal drivers of cancer risk and development. By examining the genetics of cancer in our animal relatives alongside our own, we offer a dynamic and creative approach to translational genomics. Working with collaborators from all over the country and the world, we’re able to study cancer in people, dogs, and elephants. This transdisciplinary approach continues to yield new and exciting results.
Areas of Study
- p53 and Li-Fraumeni Syndrome
- Elephant p53
- What Is Ewing Sarcoma?
- Genetic Predispositions for Ewing Sarcoma (Project GenESis)
- The Genetics of Ewing Sarcoma Tumors
Cancer in the Population
- Cancer Genetics Study
- Pediatric Biobank
News & Blog
Starting September 12, you can buy these delicious Elephant-shaped sugar cookies, dipped in white chocolate, with sprinkles at any of the 9 Kneaders locations in Colorado. 100% of sales from each cookie sale goes to benefit Dr. Josh Schiffman's Childhood Cancer Research at the Huntsman Cancer Institute.... Read More
Hyundai Hope On Wheels Presents Intermountain Primary Children's Hospital With $1 Million Hyundai Quantum Grant Award To Support Pediatric Cancer Research
Hyundai Hope On Wheels® 501c3 nonprofit organization celebrates its 20th year in the fight funding pediatric cancer research and will present Dr. Joshua Schiffman of Intermountain Primary Children's Hospital with a $1 million Hyundai Quantum Grant. This institution is one of 4 recipients of this year's award, which is the largest grant category given to support research on pediatric cancers with low survival rates.... Read More
Get to know Dr. Schiffman in this video by Circle One on Vimeo.... Read More
More than 20 researchers from Huntsman Cancer Institute (HCI) at the University of Utah made their mark on the American Association of Cancer Research (AACR) Annual Meeting this year. Held in Washington, D.C., the convention drew more than 21,500 cancer researchers from all over the world. Scientists attended sessions on topics from immunotherapy to precision medicine. About 15 researchers from HCI presented posters in the main conference hall, on a wide range of topics. ... Read More
In elephants’ cancer-resistant genes, an oncologist sees new hope for people. A few years ago pediatric oncologist Joshua Schiffman ’96 MD’00 learned an astonishing fact. Elephants have an extraordinarily low rate of cancer, despite their enormous size and long lifespan.... Read More